House Rx

Other Healthcare Technology Systems · San Francisco, CA · Founded 2021 · Privately Held (backing)

Operator of a technology-enabled service company intended to make specialty medication more accessible and affordable. House Rx is based in San Francisco, CA and was founded in 2021. It was valued at $253 million at its early-stage round in Nov 2025, the last priced event on record. It has raised $84.9 million across 1 recorded round; the latest was a $55 million Series B in Nov 2025.

PMV mark · valuation
$253.0M
Oct 2026
Priced at
its early-stage round
Nov 2025
Total raised
$84.9M
Last round
Early Stage VC (Series B)
Nov 2025
How much has House Rx raised?
$84.9Macross 1 recorded rounds · Nov 2025 – Nov 2025

Most recently, House Rx raised $55.0M in its Early Stage VC (Series B) (Nov 2025).

Free account
More of House Rx with a free account
  • ·The complete investor list: 12 names
  • ·Watch House Rx: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

House Rx round by round

1 rounds
Nov 2025Early Stage VC (Series B)$55.0M▮
+ 1 more investors · free account

How much has House Rx raised?

House Rx has raised $84.9 million in total; 1 of its rounds is on record. The largest on record was a $55 million Series B in Nov 2025.

House Rx investors

12 investors are on record for House Rx, including Khosla Ventures, Bessemer Venture Partners, New Enterprise Associates and First Round Capital. By type, the record holds 5 venture capital firms, 1 hedge fund and 1 growth equity firm. The Series B in Nov 2025 drew 6 investors.

For fundraisers
Raising for a company like House Rx?

12 investors have backed House Rx — start your target list with the firms already writing checks in other healthcare technology systems.

See all 12 investors →

Frequently asked about House Rx

How much has House Rx raised?
House Rx has raised $84.9M in total across 1 recorded funding rounds.
When was House Rx's last funding round?
House Rx's most recent recorded round was Early Stage VC (Series B) in Nov 2025, raising $55.0M.